DAAOI-P
/ China Medical University Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
November 20, 2025
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
(clinicaltrials.gov)
- P2 | N=61 | Completed | Sponsor: China Medical University Hospital | Recruiting ➔ Completed | Trial completion date: Mar 2025 ➔ Sep 2025
Trial completion • Trial completion date • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia • Movement Disorders • Parkinson's Disease
August 08, 2023
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
(clinicaltrials.gov)
- P2 | N=60 | Recruiting | Sponsor: China Medical University Hospital | Trial completion date: Mar 2023 ➔ Mar 2025 | Trial primary completion date: Dec 2022 ➔ Dec 2024
Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia • Movement Disorders • Parkinson's Disease
July 20, 2022
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
(clinicaltrials.gov)
- P2 | N=60 | Recruiting | Sponsor: China Medical University Hospital | Trial completion date: Jul 2022 ➔ Mar 2023 | Trial primary completion date: Apr 2022 ➔ Dec 2022
Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia • Movement Disorders • Parkinson's Disease
July 14, 2020
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
(clinicaltrials.gov)
- P2; N=60; Recruiting; Sponsor: China Medical University Hospital
New P2 trial • Alzheimer's Disease • CNS Disorders • Dementia • Gene Therapies • Movement Disorders • Parkinson's Disease
1 to 4
Of
4
Go to page
1